-
Mashup Score: 0Don’t Shy Away From Discussing MPN Side Effects - 11 month(s) ago
Patients being treated for a myeloproliferative neoplasm should be open with their care team about any side effects they experience, an expert said.
Source: Cure TodayCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Hope Is Paramount During Uveal Melanoma Treatment - 11 month(s) ago
An expert gives an overview of the treatment options for uveal melanoma, and why he considers hope to be an essential part of the care plan.
Source: Cure TodayCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Lining Up New Options for GIST - 11 month(s) ago
Patients with GIST have more treatment options than ever, with others currently under development.
Source: Cure TodayCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1‘There’s a Lot of Innovation’ in the KRAS-Mutant Lung Cancer Space - 11 month(s) ago
An expert discusses the ongoing SPARK trial for KRASG12-mutant non-small cell lung cancer, and what she hopes for the future of this patient population.
Source: Cure TodayCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Non-English- Speaking Patients With Cancer Face Big Barriers to Care in the U.S., But Help Is Available - 11 month(s) ago
For patients who don’t speak English, there can be additional obstacles during their cancer journey. Resources, family, care providers, fellow patients and the law are on their side.
Source: Cure TodayCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Making Magic Happen in Cancer Care - 1 year(s) ago
During an uncertain time, Missy Bean-Tanner, RN, brings inner peace and reassurance. She will jump into anything if she knows it will help her patients.
Source: Cure TodayCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Educated Patient® Multiple Myeloma Summit the Role of BMT Presentation: April 8, 2023 - 1 year(s) ago
Watch Dr. Marc Braunstein, from NYU Langone Hospital, discuss the role of bone marrow transplant during the CURE Educated Patient Multiple Myeloma Summit.
Source: Cure TodayCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6New Myeloma Therapies Are ‘A Huge Improvement for the Field’ - 1 year(s) ago
Triplet therapy demonstrates improved remission and survival rates, with manageable side effects for patients who are ineligible for transplant.
Source: Cure TodayCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2There’s ‘Unmistakable Momentum’ in MPN Advances, Expert Says - 1 year(s) ago
Dr. Naveen Pemmaraju outlines three reasons why he feels that there is “a momentum that’s unmistakable,” in the field of myeloproliferative neoplasms.
Source: Cure TodayCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Findings from a study demonstrated that patients may develop hypertension, or high blood pressure, as a result of treatment with Imbruvica for CLL, although it may be quickly managed without drug-drug interactions.
Source: Cure TodayCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Patients may feel hesitant to discuss side effects with their care team in fear of being taken off treatment. But they shouldn’t be, our Julie Huynh-Lu explains. https://t.co/8rK5hAWN0z @curetoday #EndCancer